Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Discover Cabaletta Bio's promising CAR T-cell therapy for autoimmune diseases! Durable efficacy, FDA support, and clinical potential make this attractive.

Clinically meaningful drug-free responses were observed in 3 of 4 refractory patients with immune-mediated necrotizing myopathy (IMNM), which are consistent with published data.

Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy: Phase 2 ... including immune-mediated necrotizing myopathy (IMNM), anti ...

Clinically meaningful drug-free responses were observed in 3 of 4 refractory patients with immune-mediated necrotizing myopathy (IMNM), which are consistent with published data.

Abstract. Objective To identify clinical and laboratory risk factors for Pulmonary Arterial Hypertension (PAH) in Idiopathic-Inflammatory-Myopathy (IIM) patients as well as construct a predicting ...

From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease4.

Psychological consequences of NF result from intense discomfort, painful dressing changes, and physical disfigurement and include emotions such as anxiety, fear, worry, guilt, anger, and ...

Necrotizing fasciitis is a rapidly progressive soft-tissue infection characterized by necrosis of subcutaneous tissue. The usual causative organisms are group A β-hemolytic Streptococcus and ...